Natera: A Leader in NIPT, Cord Blood Banking & Prenatal Testing

Horizon Logo Icon

Horizon™
 

Horizon™ Natera Carrier Screen

Spectrum Logo Icon

Spectrum®
 

Spectrum® Natera Preimplantation Genetics (PGS/PGD)

Panorama Logo Icon

Panorama®
 

Panorama® Natera Prenatal Screen

Vistara Logo Icon

Vistara
 

Vistara

Anora Logo Icon

Anora®
 

Anora® Natera Miscarriage Test (POC)

Evercord™
 

Evercord™ Newborn Stem Cell Banking

Constellation Logo Icon

Constellation™
 

Constellation™ Natera Technology Licensing

Signatera™
 

Signatera™ (RUO)

Reproductive testing

Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.

Learn More

Reproductive testing

Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.

Learn More

Reproductive testing

Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.

Learn More

Reproductive testing

Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.

Learn More

"Applying revolutionary technology in ways that improve the health of families is at the heart of Natera's mission."

- Matt Rabinowitz CEO and Co-Founder

Oncology testing

We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.

Learn More

Oncology testing

We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.

Learn More

Oncology testing

We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.

Learn More

Oncology testing

We're building upon our experience and expertise with cell-free DNA testing (NIPT) to achieve cutting edge advances in oncology. By applying proven scientific technology and partnering with world-leading cancer centers, we're developing products suited for early detection, therapy, and recurrence monitoring.

Learn More

November 1, 2018

Natera Announces Third Quarter 2018 Earnings Conference Call

Read More

October 18, 2018

Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine

Read More

September 13, 2018

natera.png

Natera Logo Bug

Natera Signs Agreement with Bristol-Myers Squibb

Read More

Media highlights

Natera Announces Pricing of Follow-On Offering

Read More

Media highlights

natera_icon.png

Natera To Host Investor Conference Call to Discuss Strategic Roadmap in Organ Transplantation and Oncology

Read More

Media highlights

natera_icon.png

Natera Develops Powerful Kidney Transplant Rejection Biomarker

Read More

Media highlights

Natera and Institut Jules Bordet Announce Collaboration in Neoadjuvant Breast Cancer

Read More

Media highlights

Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies

Read More

Technological Innovation

SGN_RUO_Logo_B_Color_RGB_2018bug.png

Signatera (ROU) ctDNA for cancer research

Read More

Media highlights

natera.png

Natera Logo Bug

Natera Reports First Quarter 2018 Financial Results

Read More

Technological Innovation

panorama-logo-icon.png

Panorama Logo Icon

Panorama NIPT for twins

Read More

QIAGEN and Natera Partnership

Developing cutting-edge genetic testing assays for use on QIAGEN's GeneReader

Read More

Lab solutions

Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.

 

Learn More

Lab solutions

Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.

 

Learn More

Lab solutions

Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.

 

Learn More

Lab solutions

Natera offers proprietary bioinformatic solutions that enable laboratories worldwide to expand their test offerings. Constellation manages security, storage, compliance and computational resources.

 

Learn More

Back to Top